Effectiveness of recombinant growth hormone in height deficiency due to intrauterine growth retardation;Efectividad de la hormona de crecimiento recombinante en el deficit de talla debido a retraso de crecimiento intrauterino

Medicina Clinica

Volumn 112, Issue 16, 1999, Pages 601-605

  Vicens Calvet, Enric ^a   Seijo, Guillermo ^b   Potau, Neus ^b   De Los Llanos Moreno, María ^b   Carrascosa, Antonio ^b  

^a HOSPITAL MATERNO INFANTIL VALL D HEBRON   (Spain)

^b NONE

Author keywords

[No Author keywords available]

Indexed keywords

GROWTH HORMONE; GROWTH HORMONE BINDING PROTEIN; HUMAN GROWTH HORMONE; SOMATOMEDIN BINDING PROTEIN 3; SOMATOMEDIN C;

AGE; ARTICLE; BODY GROWTH; BODY HEIGHT; BONE AGE; CHILD; CLINICAL ARTICLE; CLINICAL TRIAL; CONTROLLED CLINICAL TRIAL; CONTROLLED STUDY; DRUG EFFICACY; GLUCOSE BLOOD LEVEL; GROWTH HORMONE BLOOD LEVEL; GROWTH HORMONE RELEASE; GROWTH RATE; HUMAN; INTRAUTERINE GROWTH RETARDATION; MATURATION; PATIENT MONITORING; PRACTICE GUIDELINE; RANDOMIZED CONTROLLED TRIAL; SHORT STATURE;

AGE DETERMINATION BY SKELETON; BODY CONSTITUTION; BODY WEIGHT; CHILD; CHILD, PRESCHOOL; FEMALE; FETAL GROWTH RETARDATION; GROWTH DISORDERS; GROWTH HORMONE; HEMOGLOBINS; HUMANS; INSULIN-LIKE GROWTH FACTOR BINDING PROTEINS; INSULIN-LIKE GROWTH FACTOR I; MALE; THYROXINE;

EID: 0033535836     PISSN: 00257753     EISSN: None     Source Type: Journal    
DOI: None     Document Type: Article

References (30)

1. Karlberg J, Albertsson-Wikland K. Growth in full-term small-for-gestational-age infants: from birth to final height. Pediatr Res 1995; 38: 733-739.
2. Karlberg J, Albertsson-Wikland K, Kwuan EYW, Lam BCC, Low LCK. The timing of early postnatal catch-up growth in normal, full-term infants, born short for gestational age. Horm Res 1997; 48 (Supl 1): 17-24.
3. Davies PSW, Valley R, Preece MA. Adolescent growth and pubertal progression in Russell-Silver syndrome. Arch Dis Child 1988; 63: 130-135.
4. Gluckman PD, Harding JE. The physiology and pathophysiology of intrauterine growth retardation. Horm Res 1997; 48 (Supl 1): 11-16.
5. Lapillonne A, Peretti N, Ho PS, Claris O, Salle BL. Aetiology, morphology and body composition of infants born small for gestational age. Acta Paediatr 1997; 86 (Supl 423): 173-176.
6. Tanner JM, Whitehouse RH, Hughes PCR, Vince FP. Effect of human growth hormone treatment for 1 to 7 years on growth of 100 children with growth hormone deficiency, low birth weight, inherited smallness, Turner's syndrome and other complaints. Arch Dis Child 1971; 46: 745-782.
7. Grunt JA, Enríquez AR, Duughaday W, Budd S. Acute and long-term responses in children with idiopathic small-for-dates dwarfism. J Clin Endocrinol Metab 1972; 35: 157-168.
8. Foley TP, Thompson RG, Shaw M, Baghdassarian A, Nissley SP, Blizzard RM. Growth responses to human growth hormone in patients with intrauterine growth retardation. Pediatrics 1974; 84: 635-641.
9. Lanes R, Plotnick LP, Lee PA. Sustained effect of human growth hormone therapy on children with intrauterine growth retardation. Pediatrics 1979; 63: 731-735.
10. Albertsson-Wikland K, in collaboration with the Swedish Paediatric Group for Growth Hormone Treatment. Growth hormone secretion and growth hormone treatment in children with intrauterine growth retardation. Acata Paediatr Scand 1989; 78 (Supl 349): 35-41.
11. Rochiccioli P, Tauber M, Moisan V, Pienowsky C. Investigation of growth hormone secretion in patients with intrauterine growth retardation. Acta Paediatr Scand 1989; 78 (Supl 349): 42-46.
12. Ranke MB, Guibaud O, Lindberg A, Cole T, on behalf of the International Board of the KIGS Pharmacia International Growth Study. Prediction of the growth response in children with various growth disorders treated with growth hormone: analyses of data from the Kabi Pharmacia International Growth Study. Acta Paediatr 1993; 82 (Supl 391): 82-88.
13. Butenandt O, on behalf of the German Study Group, Löfström A, Jönsson P. Catch-up growth in short children born small for gestational age (SGA) during 2-year-therapy with growth hormone. J Pediatr Endocrinol Metab 1997; 10 (Supl 2): 275-282.
14. Zegher F, Butenandt O, Chatelain P, Albertsson-Wikland K, Jonsson B, Löfströn B et al. Growth hormone treatment in short children born small for gestational age: reappraisal of the rate bone maturation for two years and methanalysis of height gain over 4 years. Acta Paediatr 1997; 86 (Supl 423): 207-212.
15. Job JC, Chaussain JL, Job B, Ducret JP, Maes M, Olivier M et al. Follow-up of three years of treatment with growth hormone and of one post-treatment year, in children with severe growth retardation of intrauterine onset. Pediatr Res 1996; 39: 354-359.
16. Chernausek SD, Breen TJ, Frank GR. Linear growth in response to growth hormone treatment in children with short stature associated with intrauterine growth retardation: the national cooperative growth study experience. J Pediatr 1996; 128 (Supl): 22-27.
17. Papatheodorou A, Theodoridis C, Hadjiathanasiou C, Caris C, Papathanassiou A, Michalacos S. Response to growth hormone treatment in children with short stature due to intrauterine growth retardation [resumen]. Horm Res 1996; 46 (Supl 2): 41.
18. Frank GR, Cheung PT, Horn JA, Pat Alfaro M, Smith EP, Chernausek SD. Predicting the growth response to growth hormone in patients with intrauterine growth retardation. Clin Endocr 1996; 44: 679-685.
19. Albanese A, Stanhope R. GH treatment induces sustained catch-up growth in children with intrauterine growth retardation: 7-years results. Horm Res 1997; 48: 173-177.
20. Ranke MB, Lindberg A, on behalf of the KIGS International Board. Growth hormone treatment of short children born small for gestatiorial age or Russell-Silver syndrome: results from KIGS (Kabi International Growth Study) including report of final height. Acta Paediatr; 85 (Supl 417): 18-26.
21. Malvehy J, Fontan F, Iglesias J, Pérez Porcuna XM, Espigol D, Aragón C et al. Relaciön entre el peso al nacimiento y la edad de gestaciôn en una población de recién nacidos del Hospital Infantil Vall d'Hebron. Ann Esp Pediatr 1988; 28: 497-502.
22. Tanner JM, Whitehouse RH. Clinical. Longitudinal standards for height, weight, height velocity, weight velocity and stages of puberty. Arch Dis Child 1976; 51: 170-179.
23. Amit T, Barkey RJ, Youdium MBH. A new and convenient assay of growth hormone-binding protein activity in human serum. J Clin Endocrinol Metab 1990; 71: 474-479.
24. De la Puente ML, Canela J, Álvarez J, Salleras L, Vicens-Calvet E. Cross-sectional growth study of the child and adolescent population of Catalonia (Spain). Ann Human Biol 1997; 24: 435-452.
25. Boguszewki M, Ropsberg S, Albertsson-Wikland K. Spontaneous 24-hours growth hormone profiles in prepubertal small-for-gestational age children. J Clin Endocrinol Metab 1995; 80: 2.599-2.606.
26. Coutant R, Carel JC, Letrait M, Bouvatier C, Chatelain P, Coste J et al. Short stature associated with intrauterine growth retardation: final height of untreated and growth hormone-treated children. J Clin Endocrinol Metab 1998; 83: 1.070-1.074.
27. Ranke MB, Preece MA. Growth hormone treatment in short children born small for gestational age: from controversy towards consensus. Horm Res 1997; 48 (Supl 1): 72-74.
28. Barker DJP, Winter PD, Osmond C, Margetts B. Weight in infancy and death from ischaemic heart disease. Lancet 1989; 8.663: 578-581.
29. Hofman PL, Cutfield WS, Robinson EM, Bergman RN, Menon RK, Sperling MA et al. Insulin resistance in short children with intrauterine growth retardation. J Clin Endocrinol Metab 1997; 82: 402-406.
30. Hales CN. Metabolic consequences of intrauterine growth retardation. Acta Paediatr 1997; 86 (Supl 423): 184-187.